These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31076698)

  • 21. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review.
    Intiso D; Santamato A; Di Rienzo F
    Disabil Rehabil; 2017 Oct; 39(21):2123-2133. PubMed ID: 27764971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
    Hosgor H; Coskunses FM; Altindis S
    J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between wear facets, bruxism, and severity of facial pain in patients with temporomandibular disorders.
    Pergamalian A; Rudy TE; Zaki HS; Greco CM
    J Prosthet Dent; 2003 Aug; 90(2):194-200. PubMed ID: 12886214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of botulinum toxin type A: a systematic review and meta-analysis.
    Naumann M; Jankovic J
    Curr Med Res Opin; 2004 Jul; 20(7):981-90. PubMed ID: 15265242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of botulinum toxin injections on bruxism: A systematic review.
    Ågren M; Sahin C; Pettersson M
    J Oral Rehabil; 2020 Mar; 47(3):395-402. PubMed ID: 31769044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between chewing dysfunctions and temporomandibular disorders: A systematic review.
    Ferreira MC; Porto de Toledo I; Dutra KL; Stefani FM; Porporatti AL; Flores-Mir C; De Luca Canto G
    J Oral Rehabil; 2018 Oct; 45(10):819-835. PubMed ID: 29908034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bruxism after brain injury: successful treatment with botulinum toxin-A.
    Ivanhoe CB; Lai JM; Francisco GE
    Arch Phys Med Rehabil; 1997 Nov; 78(11):1272-3. PubMed ID: 9365360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attrition, occlusion, (dys)function, and intervention: a systematic review.
    van 't Spijker A; Kreulen CM; Creugers NH
    Clin Oral Implants Res; 2007 Jun; 18 Suppl 3():117-26. PubMed ID: 17594376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporomandibular Disorder Patients Benefit From Intramuscular Botulinum Toxin Type a Injections.
    Oksanen E; Männistö V; Kormi E; Vallioniemi H; Suojanen J
    J Craniofac Surg; 2022 Jun; 33(4):1159-1161. PubMed ID: 34743162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporomandibular disorders and bruxism in childhood and adolescence: review of the literature.
    Barbosa Tde S; Miyakoda LS; Pocztaruk Rde L; Rocha CP; Gavião MB
    Int J Pediatr Otorhinolaryngol; 2008 Mar; 72(3):299-314. PubMed ID: 18180045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study.
    Kaya DI; Ataoglu H
    Niger J Clin Pract; 2021 Mar; 24(3):412-417. PubMed ID: 33723117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Current Trend in Management of Bruxism and Chronic Pain: An Overview of Systematic Reviews.
    Bussadori SK; Motta LJ; Horliana ACRT; Santos EM; Martimbianco ALC
    J Pain Res; 2020; 13():2413-2421. PubMed ID: 33061557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders.
    Sipahi Calis A; Colakoglu Z; Gunbay S
    J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):322-325. PubMed ID: 30807862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of electromyographic activity in patients with temporomandibular disorders and natural mediotrusive occlusal contact during chewing and tooth grinding.
    Fuentes AD; Sforza C; Miralles R; Ferreira CL; Mapelli A; Lodetti G; Martin C
    Cranio; 2017 May; 35(3):152-161. PubMed ID: 27101810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction.
    Awan KH; Patil S; Alamir AWH; Maddur N; Arakeri G; Carrozzo M; Brennan PA
    J Oral Pathol Med; 2019 Mar; 48(3):192-200. PubMed ID: 30604895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral splints for temporomandibular disorder or bruxism: a systematic review.
    Riley P; Glenny AM; Worthington HV; Jacobsen E; Robertson C; Durham J; Davies S; Petersen H; Boyers D
    Br Dent J; 2020 Feb; 228(3):191-197. PubMed ID: 32060462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.